Houston Chronicle

Spectrum Pharma: 2012 Review

As 2012 nears its end, the rear-view mirror is full of ups and downs in the health care sector. One company that had plenty of both is small-cap Spectrum Pharmaceuticals. Here are the major milestones ...
Business Wire

Spectrum Pharmaceuticals Receives FDA Approval for ROLVEDON™ (eflapegrastim-xnst) Injection

BOSTON--(BUSINESS WIRE)--Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced that the U.S. Food and Drug ...
San Antonio Express-News

Spectrum Pharmaceuticals Earnings: An Early Look

Earnings season is now starting to wind down, with most companies already having reported their quarterly results. But there are still some companies left to report, and Spectrum Pharmaceuticals is ...
Morningstar

Spectrum Pharmaceuticals (SPPI) Lead Plaintiff Process Re-Opened, Investors with Losses Urged to Contact Hagens Berman Before September 24, 2025 Deadline

Spectrum Pharmaceuticals, Inc., et al., No. 1:22-cv-10292 (S.D.N.Y.) re-opened the lead plaintiff process and set September 24, 2025 as the deadline for investors to seek appointment as the new lead ...
Reuters

FDA delays decision on Spectrum Pharma's drug candidate due to travel curbs

Oct 26 (Reuters) - The U.S. health regulator has deferred a decision on Spectrum Pharmaceuticals' (SPPI.O), opens new tab drug candidate to treat chemotherapy induced loss of white blood cells in ...
Business Wire

Spectrum Pharmaceuticals Announces that the FDA is Deferring its Action on the BLA for ROLONTIS® (eflapegrastim)

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced that an inspection of the ...
Seeking Alpha

Assertio Holdings, Inc. Closes Spectrum Pharmaceuticals Transaction

LAKE FOREST, Ill., July 31, 2023 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc., a specialty pharmaceutical company offering differentiated products to patients, today announced that it has closed the ...
Morningstar

SPECTRUM PHARMACEUTICALS (NASDAQ: SPPI) CLASS ACTION DEADLINE APPROACHING: Berger Montague Advises Investors to Inquire About a Securities Class Action by September 24, 2025

PHILADELPHIA, Sept. 8, 2025 /PRNewswire/ -- National plaintiffs' law firm Berger Montague PC is investigating securities fraud claims against Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) ("Spectrum" ...
MarketWatch

Spectrum Pharmaceuticals (SPPI) and Assertio Holdings (ASRT) Investor Alert: Today is the Lead Plaintiff Deadline in Securities Class Action - Hagens Berman

SAN FRANCISCO, CA / ACCESS Newswire / September 24, 2025 / A New York federal court has re-opened the lead plaintiff process in the Spectrum Pharmaceuticals (SPPI) securities class action. This ...
MarketWatch

Spectrum Pharmaceuticals (SPPI) and Assertio Holdings (ASRT) Investor Alert: 6-DAY DEADLINE in Securities Lawsuit- Hagens Berman

SAN FRANCISCO, Sept. 18, 2025 /PRNewswire/ -- A New York federal court has re-opened the lead plaintiff process in the Spectrum Pharmaceuticals (SPPI) securities class action. This development offers ...
Reuters

Spectrum Pharma acquires from Indena worldwide rights to Ortataxel, a Phase 2 third generation taxane

Co and Indena S.p.A. today announced the signature of a worldwide license agreement for ortataxel, a third-generation taxane classified as a new chemical entity that has demonstrated clinical activity ...